• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2019 Fiscal Year Final Research Report

Structural biochemistry of translation-related proteins from pathogenic bacteria

Research Project

  • PDF
Project/Area Number 16K05859
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Bio-related chemistry
Research InstitutionJuntendo University (2019)
Institute of Physical and Chemical Research (2016-2018)

Principal Investigator

Yanagisawa Tatsuo  順天堂大学, 医学部, 非常勤助教 (10450420)

Project Period (FY) 2016-04-01 – 2020-03-31
Keywords翻訳 / バイオテクノロジー / タンパク質 / アミノアシルtRNA合成酵素 / tRNA / ケミカルバイオロジー / 病原性細菌 / 抗生物質
Outline of Final Research Achievements

The translation factor EF-P is a bacterial L-shaped protein that alleviates the ribosome stalling that occurs at consequtive prolines in the genetic code translation. In N. meningitidis EF-P, rhamnosylation of the arginine residue at the L-shaped tip is very important for its activity. We solved the crystal structure of the rhamnosylation enzyme EarP and the EarP / EF-P complex from N. meningitidis, and identified amino acid residues important for Arg32 rhamnosylation activity. The conformation of the rhamnose moiety is suitable for the reaction was estimated by the docking simulation, and the reaction mechanism of EF-P(Arg32) rhamnosylation was proposed.

Free Research Field

構造生物化学

Academic Significance and Societal Importance of the Research Achievements

EF-PやEF-Pの翻訳後修飾は細菌にだけ存在し、一方ヒトなどの真核生物では全く修飾が異なるeIF-5AがEF-Pの役割を担っている。ラムノシル化修飾酵素EarPは髄膜炎菌、淋菌緑膿菌、百日咳菌、セパシア菌などの臨床的に重要な病原菌にのみ存在する。従って細菌にしか存在しないEF-P修飾酵素を阻害する化合物を設計すれば感染症を引き起こす病原菌や薬剤耐性菌に対して副作用の無い有効な抗菌薬にすることが期待できる。このような阻害剤を開発することで、ヒトやその体内に存在する腸内細菌、常在細菌に悪影響を及ぼさず、特定の病原細菌のみを退治できる有効な抗菌剤の開発に繋がると期待される。

URL: 

Published: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi